Pharmacology and Therapeutics Research
Australian Venom Research Unit
Cappai laboratory: Alzheimer's disease, prion disease, Parkinson's disease and Traumatic Brain Injury
Crack laboratory: Neuropharmacology
Hughes laboratory: Drug design
Lung Health Research Centre
Stewart Laboratory: Mechanopharmacology
Affiliated with the Lung Health Research Centre (LHRC)
Wright laboratory: Cardiovascular Therapeutics Unit
- Effects of hypertension on renal and hindquarter vascular reactivity in vivo and in vitro
- Endothelin pharmacology in the setting of pulmonary hypertension
- Novel technique to determine the pKA of clonidine at prejunctional α2-adrenoceptors in sympathetic transmission
- Preclinical pharmacology – cardiovascular efficacy and safety R&D
- Reassessment of α1-adrenoceptor mechanism in artery contraction: role of ATP and pannexin channels
- The cardiovascular pharmacology of snake venoms from Papua New Guinea and Australia
- The link between cardiovascular disease and neurodegeneration – focus on Alzheimer’s disease
- Trovafloxacin – an antibiotic with additional properties